You may also like

Versant-backed Cimeio Gets $50M for Shielded Stem Cell Therapies
Versant, OrbiMed Invest $50M in Startup Inserting Genes in the Liver
Versant, RA Bet $47M on LENZ Therapeutics to Restore Near Vision in Middle Age
Stablix, Seeking to Stabilize Instead of Degrade Proteins, Raises $63M